Free Trial

BridgeBio Pharma (BBIO) Earnings Date, Estimates & Call Transcripts

BridgeBio Pharma logo
$79.29 +1.36 (+1.75%)
As of 02:07 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BridgeBio Pharma Earnings Summary

BridgeBio Pharma issued Q3 2026 earnings on October 29, 2026, reporting an EPS of -$0.42, which beat analysts' consensus estimates of -$0.54 by $0.12. Quarterly revenue rose 192.6% year-over-year to $353.17 million, above analyst estimates of $293.47 million. With a trailing EPS of -$3.04, BridgeBio Pharma's earnings are expected to grow next year, from ($2.55) to ($0.97) per share.

Latest Q3
Earnings Date
Oct. 29Estimated
Consensus EPS
(Oct. 29)
-$0.54
Actual EPS
(Oct. 29)
-$0.42 Beat By $0.12
Actual Revenue
(Oct. 29)
$353.17M

Q3 2026 Earnings Resources

Get BridgeBio Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BridgeBio Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

BBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BridgeBio Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.61-$0.61-$0.61
Q2 20261-$0.42-$0.42-$0.42
Q3 20261-$0.40-$0.40-$0.40
Q4 20261$0.13$0.13$0.13
FY 20264-$1.30-$1.30-$1.30
Q1 20271-$0.18-$0.18-$0.18
Q2 20271$0.19$0.19$0.19
Q3 20271$0.49$0.49$0.49
Q4 20271$0.79$0.79$0.79
FY 20274$1.29$1.29$1.29

BridgeBio Pharma Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026-$0.5423-$0.42+$0.1223-$0.42$293.47M$353.17M
8/10/2026Q2 2026-$0.5756-$0.78 -$0.2044-$0.78$220.91M$243.68M
5/7/2026Q1 2026-$0.70-$0.84 -$0.14-$0.84$178.07M$194.52M
2/24/2026Q4 2025-$0.75-$1.00 -$0.25-$1.00$150.71M$154.18M
10/29/2025Q3 2025-$0.88-$0.95 -$0.07-$0.95$107.71M$120.70M
8/5/2025Q2 2025-$0.83-$0.95 -$0.12-$0.95$98.46M$110.57M
4/29/2025Q1 2025-$1.00-$0.88+$0.12-$0.88$57.14M$36.74M
2/20/2025Q4 2024-$1.09-$1.31 -$0.22-$1.40$4.04M$5.88M

BridgeBio Pharma Earnings - Frequently Asked Questions

BridgeBio Pharma (NASDAQ:BBIO) last announced its quarterly earning data on Thursday, October 29, 2026. Learn more on BBIO's earnings history.

In the previous quarter, BridgeBio Pharma (NASDAQ:BBIO) reported ($0.42) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.54) by $0.12. Learn more on analysts' earnings estimate vs. BBIO's actual earnings.

The conference call for BridgeBio Pharma's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for BridgeBio Pharma's latest earnings report can be read online.
Read Transcript

BridgeBio Pharma's earnings report can be found in their filing with the SEC.
View SEC filing

BridgeBio Pharma (NASDAQ:BBIO) has a recorded annual revenue of $502.08 million.

BridgeBio Pharma (NASDAQ:BBIO) has a recorded net income of -$724.93 million. BBIO has generated -$3.04 earnings per share over the last four quarters.

BridgeBio Pharma's earnings are expected to grow from ($2.55) per share to ($0.97) per share in the next year.


Earnings data for NASDAQ:BBIO is sourced from Fiscal.ai, with the most recent quarter reported on 10/29/2026. New results are added as companies report their earnings.
From Our Partners